Healionics - News

This is an area for a new announcement or important information! Click here for more info.

24-Month Clinical results for Healionics’ STARgraft featured at CiDA conference

Posted November 4, 2025

Healionics Granted US Patent for STARgraft Technology

Posted April 2, 2025

Healionics’ STARgraft Receives FDA Breakthrough Device Designation

Posted November 14, 2024

Healionics announces 12-month clinical results for STARgraft

Posted August 7, 2024

Clinical results for Healionics’ STARgraft featured at VASA conference

Posted May 23, 2024

Healionics Awarded $1.25M NIH Grant to Support Commercialization of STARgraft Vascular Graft

Posted May 10, 2024

Healionics Closes $5.5 Million Series A-3 Financing Round

Posted February 22, 2024

Healionics selected as FiReStarter company to present at 2023 Future in Review conference

Posted December 3, 2023

Healionics named Most Valued Company at Investor Capital Expo 2023

Posted August 24, 2023

Healionics’ spinout company iSTAR reaches commercial milestone with its STAR biomaterial-based glaucoma device

Posted July 19, 2023

Healionics’ spinout company iSTAR Medical announces strategic alliance with AbbVie

Posted July 21, 2022

Tech Coast Angels’ Portfolio Company Healionics Honored with Angel Capital Association’s 2022 Luis Villalobos Award for Life Sciences

Posted May 31, 2022

Angel Capital Association honors Healionics with Villalobos Award

Posted May 23, 2022

Healionics selected as a “Top 50 Medtech Startup” in MedTech Innovator Showcase Competition

Posted June 15, 2021

Healionics raises $4.7M equity round to support commercialization of STARgraft vascular graft

Posted May 13, 2021

Healionics raises $4.5M to fund first-in-human trial of STARgraft vascular graft

Posted September 24, 2019

Healionics’ spinout company, iSTAR Medical, announces 18-month results for its MINIject glaucoma device

Posted July 10, 2019

Healionics begins first human study of its novel vascular graft

Posted April 16, 2019

Healionics featured in MedTech Strategist article on dialysis innovations

Posted January 17, 2019

Healionics honored in the winner’s circle for the Most Valued Company Award at the Northwest Angel Capital Expo 2018

Posted August 30, 2018

Healionics Welcomes New Board Director Ryan Takeuchi

Posted August 29, 2018

Healionics’ spinout company, iSTAR Medical, announces First-In-Human results of its “MINIject” for treating glaucoma

Posted May 20, 2018

Healionics Awarded $1.7M SBIR Grant from NIH to Advance New Vascular Graft Toward First-In-Human Use

Posted November 16, 2017

Healionics’ Vascular Access Device Featured at the American Society of Nephrology’s Kidney Week 2016

Posted November 17, 2016

Healionics’ Adrienne Oda in Forbes magazine’s “30 Under 30“

Posted April 22, 2016

Healionics Announces the Appointment of Mike Connolly as Chief Executive Officer

Posted March 17, 2016

Healionics Awarded $1.5M SBIR Grant from NIH to Advance Clot-Resistant Synthetic Vascular Graft for Dialysis Patients

Posted December 1, 2015

Healionics’ Adrienne Oda recognized in Manufacturing Engineering

Posted July 1, 2015

Healionics Awarded $1.3 Million Phase II NIH SBIR Grant to Advance Development of a Next-Generation Hemodialysis Access Device

Posted April 22, 2015

Healionics Awarded SBIR Contract from DOD to Develop Biointegrated Synthetic Vascular Graft

Posted December 17, 2014

Healionics Receives SBIR Grant from National Institutes of Health to Develop Needle Free Dialysis Access Devices

Posted September 8, 2014

Second Patent Issued for Healionics’ Textured STAR Biointerface

Posted February 13, 2014

Healionics’ Buddy Ratner Receives European Society for Biomaterials Award

Posted August 29, 2013

Healionics Receives ISO 13485 Certification

Posted August 22, 2013

Healionics Featured in The Economist

Posted March 9, 2013

Patent Issued for Healionics’ Textured STAR® Biointerface

Posted February 12, 2013

Patent Expands Coverage for Healionics’ STAR® Biomaterial Technology

Posted November 15, 2012

Healionics Awarded $900k Grant from NIH

Posted September 20, 2012

Healionics’ Andrew Marshall to be Awarded the Innovation / Commercialization Award at the TERMIS World Congress

Posted August 20, 2012

iSTAR Medical Receives CE Mark Approval for STARflo Glaucoma Implant

Posted July 3, 2012

Healionics’ Andrew Marshall named one of 40 Under 40 by MD+DI

Posted June 5, 2012

University of Washington and Healionics Team Up to Win Life Sciences Discovery Fund (LSDF) Award

Posted April 16, 2012

Patent Issued for Healionics’ STAR Biomaterial

Posted July 5, 2011

Dr. Andrew Marshall to Speak on STAR’s Ability to Combat Catheter-Related Infection at the Society for Biomaterials in Orlando, Florida

Posted April 8, 2011

Healionics Receives $244,500 Grant from the QTDP Program

Posted November 12, 2010

Healionics Launches iSTAR Medical with Belgian Financial Support Spinout to develop “next generation” ophthalmic implants with STAR Biomaterial

Posted October 26, 2010

Healionics to Present at AdvaMed 2010

Posted October 6, 2010

STAR Technology Helps University of Washington Researchers Repair Damaged Hearts

Posted August 9, 2010

Healionics Receives $200,000 Award from National Institutes of Health

Posted July 30, 2010

Healionics Partners with UW, Receives Washington Technology Center (WTC) Award for Infection-Reducing Biotechnology

Posted July 15, 2010

University of Washington Receives Research and Development (RTD) Award with Healionics as Company Partner

Posted July 8, 2010

Healionics to Present at the Translational Regenerative Medicine Venture Forum

Posted March 25, 2010

Dr. Andrew Marshall to Speak on STAR’s Ophthalmic Applications at the Society for Biomaterials in Seattle

Posted February 2, 2010

Dr. Buddy Ratner Presents Research on Healing and Regeneration at the Material Research Society’s Fall Meeting

Posted November 30, 2009

Healionics Receives STTR Grant from National Institutes of Health (NIH) to Develop New Artificial Cornea

Posted October 9, 2009

Healionics Selected to Present at AdvaMed 2009

Posted September 30, 2009

Dr. Buddy Ratner Receives Prestigious 2009 Acta Biomaterialia Gold Medal Award

Posted September 11, 2009

Healionics Named as Collaborating Organization in the Life Sciences Discovery Fund (LSDF) Award for Catheter Research

Posted September 2, 2009

Dr. Andrew Marshall to Present STAR® Biomaterial at World Congress of Tissue Engineering and Regenerative Medicine International Society (TERMIS)

Posted June 26, 2009

Dr. Andrew Marshall Presents STAR® Biomaterial Scaffolds for Wound Repair and Device Biointegration at Polymers in Medicine and Biology: 2009

Posted June 15, 2009

MassDevice features Healionics

Posted April 23, 2009

Healionics Takes First Step Toward Glaucoma Treatment, Appoints New CEO

Posted March 25, 2009

Healionics helps introduce glaucoma implant for dogs

Posted March 25, 2009

Healionics Ships First Commercial Product Featuring STAR Biomaterial

Posted March 24, 2009

Healionics to Present Research on STARcuff™ at Society For Biomaterials Annual Meeting

Posted March 18, 2009

Healionics Completes Series B Financing

Posted December 11, 2008

Healionics Signs Deal To Make Components for Glaucoma Device in Dogs

Posted September 9, 2008

Healionics Gets Kudos in Congress

Posted August 12, 2008

Healionics Expands Research Applications for STAR® Biomaterial Scaffold

Posted June 5, 2008

Healionics CEO Rob Brown interviewed by The Wall Street Transcript

Posted March 17, 2008

Healionics CEO Rob Brown featured in Entrepreneur magazine

Posted March 1, 2008

Healionics completes Series A Financing

Posted January 29, 2008

Healionics signs agreements to advance STAR research in implanted glucose sensor and negative pressure wound therapy applications.

Posted December 18, 2007

Healionics named “Most Promising New BioTech Firm” by Seattle Business Monthly, December 2007

Posted December 1, 2007

Healionics awarded Best Technology Investment at 2007 ZINO Zillionaire Investment Forum

Posted September 12, 2007